AT WAR OVER THE WAR ON DRUGS

In the war on drugs, a neutral zone is hard to find. The battle over
Vancouver's Insite has been a case in point. From the start, the
debate has been highly polarized. On one side are those who argue that
drug addiction is a disease and that supervised injection sites save
lives. On the other side are those who argue that we should be
treating addicts, not enabling them. Now that the Supreme Court has
put its mighty thumb on the scale, supervised injection sites will
probably spread. But don't expect the shouting match to stop.

Mark Kleiman is a veteran of the drug-rhetoric wars. The problem with
the drug debate, he says, "is that it's conducted between the
disciples of Michel Foucault and the disciples of the Marquis de
Sade." Foucault believed that the only crime is punishment. De Sade
thought the meaner the punishment, the better.

Mr. Kleiman, a bushy bearded liberal Democrat, is a professor of
public policy at UCLA and a leading expert on drug policy. His new
book, Drugs and Drug Policy: What Everyone Needs to Know, is an
invaluable guide to the facts. He favours harm-reduction programs such
as Insite. But he also thinks that people who endorse the disease
model of addiction can be just as ideological and simple-minded as the
law-and-order crowd. "Some disease proponents ignore the fact that
drug abuse is a disorder of the will," he says. "In my view, disease
and bad habits are completely consistent descriptions of the same behaviour."

Another truth that harm-reducers play down is that not all the harm of
drug abuse accrues to the user. To people in drug-ridden
neighbourhoods, the drug user is the guy who stole their television
set. The drug user is also the guy who keeps the drug dealers in business.

Harm-reducers maintain that punishing drug abusers won't change their
behaviour. Mr. Kleiman disagrees. You really can change behaviour
through sanctions, he says. You just have to have the right ones.

A case in point is the HOPE program in Hawaii. It was devised by an
innovative judge to control hard-drug use in the criminally active
population. The problem was that the probation system was inconsistent
and chaotic. Probationers got away with using illegal drugs, until
they were eventually sentenced to another lengthy stint in jail. The
judge figured there must be a better way. "You wouldn't raise a child
that way," he reasoned. "You wouldn't train a puppy that way. You'd
establish clear rules and have immediate consequences for breaking
them."

The HOPE program - which is aimed at the worst repeat offenders -
delivers swift and certain (but not severe) punishment for parole
violations. Participants are subjected to frequent random drug tests.
Anyone caught using, or who skips the test, immediately goes back to
jail for a few days. The focus isn't on treatment - it's on
compliance. The results have been remarkable. The certain prospect of
a few days behind bars makes probationers behave. Drug use has
plunged, and so has the rate of re-offence. "I hated HOPE at first
because I couldn't stay clean," one participant told Honolulu
magazine. But now she's convinced it saved her life.

"This is a remarkable form of drug treatment," says Mr. Kleiman. "You
reduce crime, shrink the drug market, and save people's lives." He
says the next step is to try out HOPE-style programs in as many
jurisdictions as possible. The U.S. government is already sponsoring
several.

Mark Kleiman's views on drug strategy displease people on both sides
of the drug wars. He believes hard drugs such as heroin, cocaine and
methamphetamines should remain illegal. Cannabis for personal use
should be allowed, but commercial distribution should also remain
illegal. It's worth noting that many of the people who back Insite are
closet (or not-so-closet) legalizers. But if you're among those who
think legalization is the answer, check out his arguments against it:
"Sometimes I think that the legalizers and the drug warriors have a
secret arms-control treaty, in which each side renounces the use of
factually and logically sound arguments."

The biggest problem with the battle over Insite is that it sucked all
the air out of the room. But drug policy is too important to be left
to ideologues. Time to get on with more creative thinking.